UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Anticoagulant drugs will add SJS Warning
The approval conditions of nine medicines that include rivaroxaban, such as...
by Lee Hye-seon
|
2017-09-13 15:55
라인
Brokerage analyzes profit-sharing structure of Celltrion group
Local stock analysts’ eyes are now on the profit-sharing structure of the C...
by Nam Doo-hyun
|
2017-09-12 16:55
라인
EU approves Abbvie’s Humira as first biologic to treat CHMP
Abbvie Korea, the Korean offshoot of the global biopharmaceutical company, ...
by Marian Chu
|
2017-09-12 15:45
라인
FIP head calls for revitalizing generic substitution
International Pharmaceutical Federation (FIP) has come forward to emphasize...
by Lee Hye-seon
|
2017-09-12 14:34
라인
Lilly’s diabetes drug ahead of Novo Nordisk’s in Q2 market share
Lilly Korea’s diabetes drug Trulicity grabbed the largest market share in K...
by Marian Chu
|
2017-09-12 13:26
라인
Sillajen stock surges upon clinical trial announcement
The share price of Sillajen, a biopharmaceutical company, has been surging ...
by Lee Han-soo
|
2017-09-12 13:26
라인
Ildong, Olix agree to develop new drugs
Ildong Pharmaceutical and Olix Pharmaceuticals, an RNA interference (RNAi)-...
by Lee Han-soo
|
2017-09-11 17:30
라인
Abbvie lands 1st place on Dow Jones Sustainability Index
Global biopharmaceutical Abbvie said Monday it has ranked number one, for t...
by Marian Chu
|
2017-09-11 14:38
라인
GSK’s HIV drug ranked No. 1 in Q2 sales
GlaxoSmithKline (GSK) said Monday its human immunodeficiency virus (HIV) tr...
by Marian Chu
|
2017-09-11 14:37
라인
FDA orders halt on Opidvo trials
Two months after the U.S. Food and Drug Administration halted Merck & Co’s ...
by Marian Chu
|
2017-09-08 16:39
라인
Vivus, Alvogen sign agreement to market diet treatment in Korea
Alvogen Korea 알보젠코리아, a pharmaceutical company, announced Friday that it ha...
by Lee Han-soo
|
2017-09-08 15:24
라인
Teva-Handok wins approval for anti-asthma injection
The Ministry of Food and Drug Safety (MFDS) approved Teva-Handok’s injectio...
by Marian Chu
|
2017-09-07 14:58
라인
Novartis Korea gains approval for skin disease biologic
The Ministry of Food and Drug Safety (MFDS) has approved biologic Xolair to...
by Marian Chu
|
2017-09-07 14:28
라인
Green Cross Cell, Maryland to cooperate for US business
Green Cross Cell, a cell treatment company, announced Wednesday that it has...
by Lee Han-soo
|
2017-09-07 11:18
라인
BMS, Pfizer prove safety for blood-thinning drug in P4 trial
Bristol-Myers Squibb and Pfizer said Wednesday their blood thinner drug Eli...
by Marian Chu
|
2017-09-06 17:40
라인
Novartis’ Revolade proved effective for seniors
Novartis Korea said Tuesday additional data analysis from its EXTEND clinic...
by Marian Chu
|
2017-09-06 12:53
라인
GemVax & KAEL names Song as new CEO
GemVax & KAEL has appointed Song Hyoung-gon 송형곤 as their new chief executiv...
by Lee Han-soo
|
2017-09-06 10:47
라인
Will Amgen’s Repatha succeed in the Korean market?
Amgen Korea released its cholesterol-lowering drug Repatha in the domestic ...
by Marian Chu
|
2017-09-06 09:07
라인
Pfizer Korea releases new tool for rheumatism injection
Pfizer Korea said Tuesday it has released an injection tool and program cal...
by Marian Chu
|
2017-09-05 17:22
라인
‘Mooncare’ helps bio, pharmaceutical stocks overcome NK risks
Amid escalating North Korea risks caused by the North’s nuclear and missile...
by Nam Doo-hyun
|
2017-09-05 16:45
-
이전
111
112
113
114
115
116
117
118
119
120
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top